RecruitingNot ApplicableNCT06501079

Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy

The Efficacy of Dexamethasone Versus Magnesium Sulphate Added to Bupivacaine Used in Erector Spinae Plane Block for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy


Sponsor

National Cancer Institute, Egypt

Enrollment

78 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Aim of the study: The current study aims to compare the effect of adding dexamethasone versus magnesium sulfate to bupivacaine in ultrasound-guided erector spinae plane block on the severity of postoperative pain. Primary Objectives: \- To compare the effect of ESPB without additives to the effect of adding dexamethasone and to the impact of adding magnesium sulfate in the form of post-operative morphine consumption


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study compares two pain-relief medications — dexamethasone and magnesium — added to a local anesthetic nerve block (called an erector spinae plane block) to control pain after kidney removal surgery (nephrectomy). It aims to find which addition works better. **You may be eligible if...** - You are an adult between 18 and 65 years old - You are scheduled to have one kidney removed (unilateral nephrectomy) - Your physical health status is classified as ASA II or III (moderate health risks) **You may NOT be eligible if...** - You refuse participation - You are under 18 - You are allergic to any of the medications used in the study - Your surgical incision will run down the middle of the abdomen (midline incision) - You are having both kidneys removed - You have a deformed or unusual spine anatomy (such as kyphoscoliosis) - You have a known nerve or psychiatric disorder, or chronic pain condition - You have a local infection at the injection site - You are in an unstable medical state (hemodynamic instability) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREultrasound guided Erector Spinae Plane Block using 27ml bupivacaine 0.25%

ESP block will be performed U/S at the level of T 10 paraspinal level. The ultrasound transducer should be placed in the midline of the back at the desired level. The probe should then slowly be moved laterally until the transverse process is visible. The transverse process requires differentiation from the rib at that level. Erector spinae muscle should be identified superficial to the transverse process. The needle inserted superior to the ultrasound probe in the cephalad to caudal direction. Once the needle tip is below the erector spinae muscle. This separation from the transverse process confirms the proper needlemposition. The local anesthetic should then be injected in 5 ml increments. The block will be performed preoperatively.


Locations(1)

National Cancer institute - Cairo University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06501079


Related Trials